Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system

Mariano Licciardi, Cinzia Scialabba, Gaetano Giammona, Marco Paolino, Giorgio Grisci, Vincenzo Razzano, Francesco Makovec, Andrea Cappelli, Germano Giuliani

Risultato della ricerca: Article

6 Citazioni (Scopus)

Abstract

A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.
Lingua originaleEnglish
pagine (da-a)197-208
Numero di pagine12
RivistaJournal of Nanoparticle Research
Volume19
Stato di pubblicazionePublished - 2017

Fingerprint

Drug Delivery
Brushes
Hyaluronic Acid
Receptor
Nanoparticles
delivery
drugs
brushes
nanoparticles
Polymers
Cell
Cancer
Doxorubicin
Bearings (structural)
cancer
Cells
Medical nanotechnology
Drugs
Hyaluronic acid
Nanomedicine

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Atomic and Molecular Physics, and Optics
  • Chemistry(all)
  • Modelling and Simulation
  • Materials Science(all)
  • Condensed Matter Physics

Cita questo

Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system. / Licciardi, Mariano; Scialabba, Cinzia; Giammona, Gaetano; Paolino, Marco; Grisci, Giorgio; Razzano, Vincenzo; Makovec, Francesco; Cappelli, Andrea; Giuliani, Germano.

In: Journal of Nanoparticle Research, Vol. 19, 2017, pag. 197-208.

Risultato della ricerca: Article

Licciardi, Mariano ; Scialabba, Cinzia ; Giammona, Gaetano ; Paolino, Marco ; Grisci, Giorgio ; Razzano, Vincenzo ; Makovec, Francesco ; Cappelli, Andrea ; Giuliani, Germano. / Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system. In: Journal of Nanoparticle Research. 2017 ; Vol. 19. pagg. 197-208.
@article{58028ffc97b74e019840f7c7ba878b49,
title = "Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system",
abstract = "A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350{\^A} nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.",
author = "Mariano Licciardi and Cinzia Scialabba and Gaetano Giammona and Marco Paolino and Giorgio Grisci and Vincenzo Razzano and Francesco Makovec and Andrea Cappelli and Germano Giuliani",
year = "2017",
language = "English",
volume = "19",
pages = "197--208",
journal = "Journal of Nanoparticle Research",
issn = "1388-0764",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system

AU - Licciardi, Mariano

AU - Scialabba, Cinzia

AU - Giammona, Gaetano

AU - Paolino, Marco

AU - Grisci, Giorgio

AU - Razzano, Vincenzo

AU - Makovec, Francesco

AU - Cappelli, Andrea

AU - Giuliani, Germano

PY - 2017

Y1 - 2017

N2 - A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.

AB - A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.

UR - http://hdl.handle.net/10447/248539

UR - http://www.kluweronline.com/issn/1388-0764

M3 - Article

VL - 19

SP - 197

EP - 208

JO - Journal of Nanoparticle Research

JF - Journal of Nanoparticle Research

SN - 1388-0764

ER -